| Peer-Reviewed

Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016

Received: 12 July 2017     Accepted: 28 July 2017     Published: 6 September 2017
Views:       Downloads:
Abstract

Tuberculosis is a major public health concern in Nigeria. It had been targeted for elimination using the directly observed treatment short Couse strategy. Plateau state started implementing the strategy since 2001. The key performance indicators towards achieving elimination targets was evaluated. Data from the routine surveillance records and reports from 2008 to 2015 were extracted. Patients’ enrollment, sputum conversion, treatment outcomes and TB/HIV co-infection was analyzed using epiInfo software. Of the 23,532 registered cases, only 34% were new sputum smear positive. The introduction of XpertMTB/Rif technology in 2013 increased the proportion of patient with pulmonary TB diagnosed bacteriologically by 11%. Majority (89%) of the smear positive cases were in the productive age group of 15 – 54 years. TB/HIV co-infection was 39.6%, with more female than male (OR 2.41, 95% CI: 2.22 – 2.63). The cured rate increased from 57.3% in 2008 to 70.1% in 2014. The overall treatment success and death rates were 83.0% and 6.6% respectively. Deaths and treatment failure rates were lower among new pulmonary smear positive patients (OR 0.68, 95% CI 0.52 – 0.88 and OR 0.47, 95% CI 0.29 – 0.77) respectively. The deaths were higher among TB/HIV compared to HIV negative patients (OR 2.23, 95%: 1.84 – 2.70). Despites the improvements in the performance indicators, the state is yet to achieve the elimination targets. Expansion of the use of Xpert technology, Community awareness, patient education and prompt defaulter retrieval will ensure early detection and enrollment of cases, improve quality of diagnosis and outcomes of TB treatment in the state.

Published in Central African Journal of Public Health (Volume 3, Issue 5)
DOI 10.11648/j.cajph.20170305.12
Page(s) 61-67
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2017. Published by Science Publishing Group

Keywords

Tuberculosis, Case Notification, Diagnosis, XpertMTB/Rif, Treatment Outcomes

References
[1] What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. WHO/CDS/CPC/TB/99.270.
[2] WHO. Global tuberculosis report 2015. WHO/HTM/TB/2015.22
[3] Federal Ministry of Health Nigeria, Report: First National TB Prevalence Survey 2012, Nigeria. Federal Ministry of Health Nigeria.
[4] Federal Ministry of Health Nigeria, National TB and leprosy control program workers manual; 2008. Federal Ministry of Health Nigeria.
[5] WHO. Treatment of Tuberculosis Guidelines – 4th ed., WHO/HTM/TB/2009. 420.
[6] Federal Ministry of Health Nigeria, National Tuberculosis, leprosy and Buruli Ulcer Management and Control Guidelines Sixth edition, 2015. Federal Ministry of Health Nigeria.
[7] Federal Ministry of Health Nigeria, National TB and leprosy control program workers manual; 2008. Federal Ministry of Health, Nigeria.
[8] Small P M. and Pai, M Tuberculosis Diagnosis — Time for a Game Change. N Engl J Med 2010; 363: 1070-1071.
[9] WHO, Revised TB recording and reporting forms and registers – version 2006. Geneva, World Health Organization, 2006. (WHO/HTM/TB/2006.373).
[10] WHO, The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva, World Health Organization, 2006 (WHO/HTM/TB/2006. 368).
[11] WHO, Implementing the Stop TB Strategy: a handbook for national tuberculosis control programs, Geneva, World health Organization. 2008 (WHO/HTM/TB/2008. 401).
[12] WHO, The global MDR-TB and XDR-TB response Plan, 2007-2008 WHO/HTM/TB/2007.387.
[13] World Health Organization, TB/HIV Clinical Manual 2nd Edition, 2004; WHO/HTM/TB/2004. 329.
[14] Federal Ministry of Health Abuja Nigeria, National TB and leprosy control program workers manual 5th edition, 2010.
[15] Plateau state ministry of health, Annual report of the Plateaus state TBL control report, 2001.
[16] Federal ministry of health Nigeria department of public health guidelines for community tuberculosis care in Nigeria national tuberculosis and leprosy control program June.
[17] Federal ministry of health, technical report 2010, National HIV sero-prevalence survey among pregnant women attending Antenatal clinics in Nigeria.
[18] Plateau state ministry of health, Plateau state Health statistical bulletin, 2012.
[19] Plateau state ministry of health, Annual report of the Plateaus state TBL control report, 2011.
[20] Plateau state ministry of health, Plateau state Health statistical bulletin, 2014.
[21] WHO. Definitions and Reporting Framework for Tuberculosis – 2013 Revision (WHO/HTM/TB/2013.2).
[22] Akinola A. Fatiregun, Abimbola S. Ojo, Afolabi E. Bamgboye. Treatment outcomes among pulmonary tuberculosis patients at treatment centers in Ibadan, Nigeria. Annals of African Medicine.2009, (8)2: 100-104.
[23] Alobu I, Oshi Dl C., Oshi S N. and Ukwaja K N. Profile and determinants of treatment failure among smear-positive pulmonary tuberculosis patients in Ebonyi, Southeastern Nigeria. International Journal of Mycobacteriology 3 (2014) 127-131.
[24] Dye C, Williams B G, Espinal M A, Raviglione M C, Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis Science 15, 2002; 295 (5562). 2042-2046 DOI: 10.1126/science. 1063814.
[25] Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006; 194: 479-85.
[26] Odaibo G., Okonkwo P., Lawal O and Olaleye D. "HIV Infection among Newly Diagnosed TB Patients in Southwestern Nigeria: A Multi-DOTS Center Study," World Journal of AIDS, Vol. 3 No. 2, 2013, pp. 154-159. doi: 10.4236/wja.2013. 32020.
[27] Chuks O R, Anyabolu A E, Ifeanyi C M, Kalu S, Onwunzo M C, Chukwuka C. Prevalence of HIV Infection in Pulmonary Tuberculosis Suspects; Assessing the Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. Advances in Life Science and Technology 2013, Vol 14, 87.
[28] Pennap G, Makpa S, Ogbu S. The Prevalence of HIV/AIDS among Tuberculosis Patients in a Tuberculosis/Leprosy Referral Center in Alushi, Nasarawa State, Nigeria. The Internet Journal of Epidemiology. 2009 (8) 1.
[29] Nwabuko C. O, Ejele O. A, Chuku A, Nnoli M. A, Chukwuonye I. I. Prevalence of Tuberculosis-HIV Co-infection and Relationship between Tuberculosis and CD4/ESR in HIV Patients in Niger Delta Region of Nigeria. IOSR Journal of Dental and Medical Sciences (JDMS) 2012. 2 (4) 01-04.
[30] Ahmed W. A, Prajapati R. K. and Bilkisu B. Y. ³ Incidence of Tuberculosis among Human Immunodeficiency Virus (HIV) patients attending General Hospital Bajoga IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-ISSN: 2278-3008, p-ISSN: 2319-7676. Volume 7, Issue 5 (Sep. – Oct. 2013), PP 69-72.
[31] Gao J, Zheng P, Fu H (2013) Prevalence of TB/HIV Co-Infection in Countries Except China: A Systematic Review and Meta-Analysis. PLoS ONE 8 (5): e64915. doi: 10.1371/journal.pone. 0064915.
[32] Albuquerque MFPM, Ximenes RAA, Lucena-Silva N, Souza W V, Dantas A T, Dantas OMS and Rodrigues L C. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad. Saúde Pública, Rio de Janeiro, jul 2007, 23 (7): 1573-1582.
[33] Federal ministry of health, National TB and Leprosy indicator reference book, July 2011.
[34] Indicators for Program Outcomes. Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs. WHO/HTM/TB/2004.344.
[35] Babalık A, Kılıcaslan Z, Kızıltaş Ş, Gencer S, Ongen G. A Retrospective Case-Control Study, Factors Affecting Treatment Outcomes for Pulmonary Tuberculosis in İstanbul, Turkey. Balkan Med J 2013; 30: 204-10 • DOI: 10.5152/balkanmedj. 2013.005.
[36] Jha U. M, Satyanarayana S, Dewan P. K, Chadha S, Wares F, et al. (2010) Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006. PLoS ONE 5 (1): e8873. doi: 10.1371/journal.pone.0008873 accessed 26/01/2015.
[37] O’Boyle S. J. O, Power J. J, Ibrahim M. Y, Watson J. P. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis 2002, 6 (4): 307–312.
Cite This Article
  • APA Style

    Luka Mangveep Ibrahim, Gonen Mato Lakda, Samuel Ogiri, Phillip Patrobas, Danjuma Maku Aboki. (2017). Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016. Central African Journal of Public Health, 3(5), 61-67. https://doi.org/10.11648/j.cajph.20170305.12

    Copy | Download

    ACS Style

    Luka Mangveep Ibrahim; Gonen Mato Lakda; Samuel Ogiri; Phillip Patrobas; Danjuma Maku Aboki. Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016. Cent. Afr. J. Public Health 2017, 3(5), 61-67. doi: 10.11648/j.cajph.20170305.12

    Copy | Download

    AMA Style

    Luka Mangveep Ibrahim, Gonen Mato Lakda, Samuel Ogiri, Phillip Patrobas, Danjuma Maku Aboki. Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016. Cent Afr J Public Health. 2017;3(5):61-67. doi: 10.11648/j.cajph.20170305.12

    Copy | Download

  • @article{10.11648/j.cajph.20170305.12,
      author = {Luka Mangveep Ibrahim and Gonen Mato Lakda and Samuel Ogiri and Phillip Patrobas and Danjuma Maku Aboki},
      title = {Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016},
      journal = {Central African Journal of Public Health},
      volume = {3},
      number = {5},
      pages = {61-67},
      doi = {10.11648/j.cajph.20170305.12},
      url = {https://doi.org/10.11648/j.cajph.20170305.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20170305.12},
      abstract = {Tuberculosis is a major public health concern in Nigeria. It had been targeted for elimination using the directly observed treatment short Couse strategy. Plateau state started implementing the strategy since 2001. The key performance indicators towards achieving elimination targets was evaluated. Data from the routine surveillance records and reports from 2008 to 2015 were extracted. Patients’ enrollment, sputum conversion, treatment outcomes and TB/HIV co-infection was analyzed using epiInfo software. Of the 23,532 registered cases, only 34% were new sputum smear positive. The introduction of XpertMTB/Rif technology in 2013 increased the proportion of patient with pulmonary TB diagnosed bacteriologically by 11%. Majority (89%) of the smear positive cases were in the productive age group of 15 – 54 years. TB/HIV co-infection was 39.6%, with more female than male (OR 2.41, 95% CI: 2.22 – 2.63). The cured rate increased from 57.3% in 2008 to 70.1% in 2014. The overall treatment success and death rates were 83.0% and 6.6% respectively. Deaths and treatment failure rates were lower among new pulmonary smear positive patients (OR 0.68, 95% CI 0.52 – 0.88 and OR 0.47, 95% CI 0.29 – 0.77) respectively. The deaths were higher among TB/HIV compared to HIV negative patients (OR 2.23, 95%: 1.84 – 2.70). Despites the improvements in the performance indicators, the state is yet to achieve the elimination targets. Expansion of the use of Xpert technology, Community awareness, patient education and prompt defaulter retrieval will ensure early detection and enrollment of cases, improve quality of diagnosis and outcomes of TB treatment in the state.},
     year = {2017}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Progress Towards TB Elimination: An Eight-Year Retrospective Analysis of Key Performance Indicators for TB Control in Plateau State, Nigeria, 2016
    AU  - Luka Mangveep Ibrahim
    AU  - Gonen Mato Lakda
    AU  - Samuel Ogiri
    AU  - Phillip Patrobas
    AU  - Danjuma Maku Aboki
    Y1  - 2017/09/06
    PY  - 2017
    N1  - https://doi.org/10.11648/j.cajph.20170305.12
    DO  - 10.11648/j.cajph.20170305.12
    T2  - Central African Journal of Public Health
    JF  - Central African Journal of Public Health
    JO  - Central African Journal of Public Health
    SP  - 61
    EP  - 67
    PB  - Science Publishing Group
    SN  - 2575-5781
    UR  - https://doi.org/10.11648/j.cajph.20170305.12
    AB  - Tuberculosis is a major public health concern in Nigeria. It had been targeted for elimination using the directly observed treatment short Couse strategy. Plateau state started implementing the strategy since 2001. The key performance indicators towards achieving elimination targets was evaluated. Data from the routine surveillance records and reports from 2008 to 2015 were extracted. Patients’ enrollment, sputum conversion, treatment outcomes and TB/HIV co-infection was analyzed using epiInfo software. Of the 23,532 registered cases, only 34% were new sputum smear positive. The introduction of XpertMTB/Rif technology in 2013 increased the proportion of patient with pulmonary TB diagnosed bacteriologically by 11%. Majority (89%) of the smear positive cases were in the productive age group of 15 – 54 years. TB/HIV co-infection was 39.6%, with more female than male (OR 2.41, 95% CI: 2.22 – 2.63). The cured rate increased from 57.3% in 2008 to 70.1% in 2014. The overall treatment success and death rates were 83.0% and 6.6% respectively. Deaths and treatment failure rates were lower among new pulmonary smear positive patients (OR 0.68, 95% CI 0.52 – 0.88 and OR 0.47, 95% CI 0.29 – 0.77) respectively. The deaths were higher among TB/HIV compared to HIV negative patients (OR 2.23, 95%: 1.84 – 2.70). Despites the improvements in the performance indicators, the state is yet to achieve the elimination targets. Expansion of the use of Xpert technology, Community awareness, patient education and prompt defaulter retrieval will ensure early detection and enrollment of cases, improve quality of diagnosis and outcomes of TB treatment in the state.
    VL  - 3
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Public Health, Ministry of Health, Jos, Nigeria

  • Department of Public Health, Ministry of Health, Jos, Nigeria

  • Tuberculosis Control Cluster, World Health Organization, Abuja, Nigeria

  • Tuberculosis Control Cluster, World Health Organization, Abuja, Nigeria

  • Department of Public Health, Ministry of Health, Lafia, Nigeria

  • Sections